Recent Finacing
Recent Raise
Ascletis is a U.S.–China biopharma that in-licenses and develops clinical-stage antivirals and RNAi therapeutics for hepatitis C, HIV and liver cancer, operating R&D and commercialization in China and U.S.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Ascletis.
